Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER 137 OTHER_GOV 7 NETWORK 5 NIH 2 INDUSTRY 1

Study Type

Interventional 18 Observational 1

Sponsor

Conditions

Breast Neoplasms 468 Neoplasms 316 Carcinoma, Non-Small-Cell Lung 269 Prostatic Neoplasms 215 Colorectal Neoplasms 208 Lung Neoplasms 178 Multiple Myeloma 123 Melanoma 110 Carcinoma, Renal Cell 107 Ovarian Neoplasms 94 Carcinoma, Hepatocellular 78 Pancreatic Neoplasms 69 Urinary Bladder Neoplasms 65 Stomach Neoplasms 64 Neoplasm Metastasis 64 Leukemia, Lymphocytic, Chronic, B-Cell 62 Colonic Neoplasms 60 Leukemia, Myeloid, Acute 53 Uterine Cervical Neoplasms 50 Recurrence 49 Liver Neoplasms 46 Lymphoma, Follicular 45 Lymphoma 45 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 39 Esophageal Neoplasms 37 Precursor Cell Lymphoblastic Leukemia-Lymphoma 36 Lymphoma, Large B-Cell, Diffuse 35 Hematologic Neoplasms 35 Head and Neck Neoplasms 35 Lymphoma, Non-Hodgkin 34

Interventions

regorafenib 1 Sorafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Observational × COVID-19 × Clear all

NCT05594147 2023-11-07

ROCURS

Bayer

COVID-19

Data powered by HemOnc (CC BY 4.0) Colophon ⚡